Previous close | 2.7200 |
Open | 2.7000 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's range | 2.5400 - 2.7000 |
52-week range | 2.3000 - 26.5500 |
Volume | |
Avg. volume | 32,502 |
Market cap | 1.479M |
Beta (5Y monthly) | 0.83 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Dermata (DRMA) announces reaching an agreement with the FDA to begin a late-stage pivotal clinical program for its acne treatment candidate, DMT310. The stock rises 7%.